381 related articles for article (PubMed ID: 36726376)
1. Prognostic and diagnostic values of non-coding RNAs as biomarkers for breast cancer: An umbrella review and pan-cancer analysis.
Bahramy A; Zafari N; Rajabi F; Aghakhani A; Jayedi A; Khaboushan AS; Zolbin MM; Yekaninejad MS
Front Mol Biosci; 2023; 10():1096524. PubMed ID: 36726376
[No Abstract] [Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. The diagnostic and prognostic value of exosome-derived long non-coding RNAs in cancer patients: a meta-analysis.
Mu H; Zhang S; Yao Z; Liu Y; Lin K; Zhao Z; Zhu Y
Clin Exp Med; 2020 Aug; 20(3):339-348. PubMed ID: 32504320
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic and prognostic potential of exosome non-coding RNAs in bladder cancer: a systematic review and meta-analysis.
Chen Y; Shi K; Fu X; Guo H; Gao T; Yu H
Front Oncol; 2024; 14():1336375. PubMed ID: 38500660
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNAs (lncRNAs) as prognostic and diagnostic biomarkers in multiple myeloma: A systematic review and meta-analysis.
Mardani M; Rashedi S; Keykhaei M; Farrokhpour H; Azadnajafabad S; Tavolinejad H; Rezaei N
Pathol Res Pract; 2022 Jan; 229():153726. PubMed ID: 34942515
[TBL] [Abstract][Full Text] [Related]
6. Circulating Non-coding RNAs as Potential Biomarkers for Ischemic Stroke: A Systematic Review.
Zhao J; Wang Q; Zhu R; Yang J
J Mol Neurosci; 2022 Aug; 72(8):1572-1585. PubMed ID: 35380333
[TBL] [Abstract][Full Text] [Related]
7. Prognosis difference between HER2-low and HER2-zero breast cancer patients: a systematic review and meta-analysis.
Li C; Yuan Q; Deng T; Xu G; Hou J; Zheng L; Wu G
Breast Cancer; 2023 Nov; 30(6):965-975. PubMed ID: 37470943
[TBL] [Abstract][Full Text] [Related]
8. Pre-treatment Glasgow prognostic score and modified Glasgow prognostic score may be potential prognostic biomarkers in urological cancers: a systematic review and meta-analysis.
Qi F; Xu Y; Zheng Y; Li X; Gao Y
Ann Transl Med; 2019 Oct; 7(20):531. PubMed ID: 31807513
[TBL] [Abstract][Full Text] [Related]
9. lncRNAs as prognostic molecular biomarkers in hepatocellular carcinoma: a systematic review and meta-analysis.
Zheng C; Liu X; Chen L; Xu Z; Shao J
Oncotarget; 2017 Aug; 8(35):59638-59647. PubMed ID: 28938667
[TBL] [Abstract][Full Text] [Related]
10. Circulating exosomal microRNAs as potential prognostic biomarkers in gastrointestinal cancers: a systematic review and meta-analysis.
Gheytanchi E; Tajik F; Razmi M; Babashah S; Cho WCS; Tanha K; Sahlolbei M; Ghods R; Madjd Z
Cancer Cell Int; 2023 Jan; 23(1):10. PubMed ID: 36670440
[TBL] [Abstract][Full Text] [Related]
11. The Impact of lncRNA Dysregulation on Clinicopathology and Survival of Breast Cancer: A Systematic Review and Meta-analysis.
Tian T; Wang M; Lin S; Guo Y; Dai Z; Liu K; Yang P; Dai C; Zhu Y; Zheng Y; Xu P; Zhu W; Dai Z
Mol Ther Nucleic Acids; 2018 Sep; 12():359-369. PubMed ID: 30195774
[TBL] [Abstract][Full Text] [Related]
12. Gene expression profiling for guiding adjuvant chemotherapy decisions in women with early breast cancer: an evidence-based and economic analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(23):1-57. PubMed ID: 23074401
[TBL] [Abstract][Full Text] [Related]
13. Clinical Values of Long Non-coding RNAs in Bladder Cancer: A Systematic Review.
Su G; He Q; Wang J
Front Physiol; 2018; 9():652. PubMed ID: 29899709
[No Abstract] [Full Text] [Related]
14. The prognostic role of tumor mutation burden on survival of breast cancer: a systematic review and meta-analysis.
Ke L; Li S; Cui H
BMC Cancer; 2022 Nov; 22(1):1185. PubMed ID: 36397030
[TBL] [Abstract][Full Text] [Related]
15. CCNB2 expression correlates with worse outcomes in breast cancer patients: a pooled analysis.
Sun C; Lowe S; Ma S; Bentley R; Zhou Z; Cheng C; Zhou Q
Women Health; 2022 Aug; 62(7):655-663. PubMed ID: 35892137
[TBL] [Abstract][Full Text] [Related]
16. The roles of ncRNAs in the diagnosis, prognosis and clinicopathological features of breast cancer: a systematic review and meta-analysis.
Tang S; Fan W; Xie J; Deng Q; Wang P; Wang J; Xu P; Zhang Z; Li Y; Yu M
Oncotarget; 2017 Oct; 8(46):81215-81225. PubMed ID: 29113381
[TBL] [Abstract][Full Text] [Related]
17. The prognostic value of circulating cell-free DNA in breast cancer: A meta-analysis.
Tan G; Chu C; Gui X; Li J; Chen Q
Medicine (Baltimore); 2018 Mar; 97(13):e0197. PubMed ID: 29595655
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of exosomal noncoding RNA in hepatocellular carcinoma: a meta-analysis.
Nie G; Lian N; Peng D; Lu J; Li B
Carcinogenesis; 2022 Sep; 43(8):754-765. PubMed ID: 35904534
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA as a potential diagnostic and prognostic biomarker in melanoma: A systematic review and meta-analysis.
Masrour M; Khanmohammadi S; Fallahtafti P; Hashemi SM; Rezaei N
J Cell Mol Med; 2024 Feb; 28(3):e18109. PubMed ID: 38193829
[TBL] [Abstract][Full Text] [Related]
20. High Ki-67 Immunohistochemical Reactivity Correlates With Poor Prognosis in Bladder Carcinoma: A Comprehensive Meta-Analysis with 13,053 Patients Involved.
Luo Y; Zhang X; Mo M; Tan Z; Huang L; Zhou H; Wang C; Wei F; Qiu X; He R; Chen G
Medicine (Baltimore); 2016 Apr; 95(15):e3337. PubMed ID: 27082587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
